Gå till sökfältet
Gå till sidans huvudinnehåll
Gå till tillgänglighetsredogörelsen
Forskning.fi
Menu
Suomeksi
På svenska
In English
Ingångssida
Sökning
Vetenskaps- och innovationspolitik
Vetenskaps- och forskningsnyheter
På svenska
- 492 results
Publikationer
492
Utlysningar
0
Beviljade finansiering
0
Personer
0
Data
0
Infrastrukturer
0
Organisationer
0
Projekt
0
Publikationer -
492
sökresultat
Gå till sökresultaten
Visa som bild
Begränsa sökning
Resultaten visas 1 - 10 / 492
10
50
100
resultat / per sida
Vilka
publikations
uppgifter finns i tjänsten?
Icon
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory
Indolent
Lymphoma
Referentgranskad
DOI
10.1200/JCO.2017.75.4648
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George A.; Lenz, Georg;...
Journal of clinical oncology
2017
Publicationer information ikon
FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular
lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1002/cam4.4924
Rajamäki, Aino; Kuitunen, Hanne; Sorigue, Marc; Kokkonen, Salla‐Maarit; Kuittinen, Outi; Sunela, Kai...
Cancer medicine
2022
Publicationer information ikon
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed
Indolent
B-cell
Lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1016/j.clml.2021.06.021
Matasar, Matthew J.; Dreyling, Martin; Leppä, Sirpa; Santoro, Armando; Pedersen, Michael; Buvaylo, V...
Clinical
lymphoma
myeloma and leukemia
2021
Publicationer information ikon
Short regimen of rituximab plus lenalidomide in follicular
lymphoma
patients in need of first-line therapy
Referentgranskad
DOI
10.1182/blood-2018-10-879643
Swiss Grp Clinical Canc Res; Nordic
Lymphoma
Grp; Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna...
Blood
2019
Publicationer information ikon
Different chemokine profile between systemic and testicular diffuse large B-cell
lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1080/10428194.2021.1913150
Ollikainen, Riina K; Kotkaranta, Pyry H; Kemppainen, Janette; Teppo, Hanna-Riikka; Kuitunen, Hanne; ...
Leukemia &
lymphoma
2021
Publicationer information ikon
Primary cutaneous follicle center
lymphoma
within a tattoo
DOI
10.1016/j.annder.2022.03.004
Kluger, Nicolas; Jeskanen, Leila; Cajanus, Suvi; Lappalainen, Katriina
Annales de dermatologie et de venereologie
2022
Publicationer information ikon
Oxidative stress in diffuse large B-cell
lymphoma
and follicular
lymphoma
, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell
lymphoma
Öppen tillgång
Peroja, Pekka
Acta Universitatis Ouluensis. Series D, Medica
2018
Publicationer information ikon
Malignant
lymphoma
presenting as bilateral sensorineural hearing loss-A case report
Referentgranskad
Öppen tillgång
DOI
10.1002/ccr3.6711
Raunio, Frida; Kelppe, Jetta; Hafren, Lena
Clinical case reports
2022
Publicationer information ikon
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory
indolent
lymphoma
:2-year follow-up of the CHRONOS-1 study
Referentgranskad
Öppen tillgång
DOI
10.1002/ajh.25711
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppae, Sirpa; Follows, George; Lenz, Georg; K...
American journal of hematology
2020
Publicationer information ikon
Venous thromboembolism in children with Hodgkin
lymphoma
: A population-based study in Sweden, Finland, and Denmark
Referentgranskad
Öppen tillgång
DOI
10.1016/j.thromres.2025.109287
Giertz, Mia; Aarnivala, Henri; Michelsen, Sascha W.; Björklund, Caroline; Grönroos, Marika; Hjalgrim...
Thrombosis research
2025
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory
Indolent
Lymphoma
Referentgranskad
DOI
10.1200/JCO.2017.75.4648
2017
FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular
lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1002/cam4.4924
2022
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed
Indolent
B-cell
Lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1016/j.clml.2021.06.021
2021
Short regimen of rituximab plus lenalidomide in follicular
lymphoma
patients in need of first-line therapy
Referentgranskad
DOI
10.1182/blood-2018-10-879643
2019
Different chemokine profile between systemic and testicular diffuse large B-cell
lymphoma
Referentgranskad
Öppen tillgång
DOI
10.1080/10428194.2021.1913150
2021
Primary cutaneous follicle center
lymphoma
within a tattoo
DOI
10.1016/j.annder.2022.03.004
2022
Oxidative stress in diffuse large B-cell
lymphoma
and follicular
lymphoma
, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell
lymphoma
Öppen tillgång
2018
Malignant
lymphoma
presenting as bilateral sensorineural hearing loss-A case report
Referentgranskad
Öppen tillgång
DOI
10.1002/ccr3.6711
2022
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory
indolent
lymphoma
:2-year follow-up of the CHRONOS-1 study
Referentgranskad
Öppen tillgång
DOI
10.1002/ajh.25711
2020
Venous thromboembolism in children with Hodgkin
lymphoma
: A population-based study in Sweden, Finland, and Denmark
Referentgranskad
Öppen tillgång
DOI
10.1016/j.thromres.2025.109287
2025
Föregående
1
2
3
4
5
Nästa
Resultaten visas 1 - 10 / 492
Sida 1
Sort